Senior Director, US Product Planning

Key Responsibilities

• Represent the US commercial perspective on global asset teams for early pipeline assets (~3–4 years from launch).
• Lead development of US commercial strategy with global commercial, medical, market access, HEOR, analytics, operations, and finance.
• Translate asset strategy into a US launch blueprint: market development priorities; launch scenarios/assumptions; capability requirements; organization design implications; field force & non-personal promotion considerations; budget/investment needs.
• Frame strategic choices: positioning; patient finding & market development; access & reimbursement readiness; evidence generation; customer engagement model; patient services/support.
• Create milestone- and scenario-based plans to prepare for launch before traditional pre-launch planning.
• Partner cross-functionally to define capabilities, talent, processes, and infrastructure; assess readiness and recommend build/buy/borrow.
• Provide input on US commercialization models (specialty, institution-based, buy-and-bill markets); support governance with recommendations, tradeoffs, and risk assessments.
• Enable smooth transition from early planning to launch readiness and in-market execution.
• Help define the strategic and organizational foundations of a new Business Unit.

• Significant biotech/pharma experience in commercial strategy, new product planning, marketing, or launch strategy.
• Experience in both US commercial/business roles and global/enterprise asset/team roles.
• Success in new product planning/pre-launch/launch planning.
• Deep experience in neurology and/or rare disease.
• Strong understanding of US commercialization in complex specialty markets (buy-and-bill, access/site-of-care/reimbursement).
• Experience building resourcing plans, operating models, and capability roadmaps.
• Ability to influence senior stakeholders in a matrix environment.
• Cross-functional collaboration across commercial, medical, market access, analytics, operations, finance, and patient services.

• US commercial planning/brand leadership/business leadership.
• Global asset team/global commercial strategy experience.
• Specialty/complex launch environment experience; development-to-launch readiness exposure.
• Provider-administered therapy and buy-and-bill commercialization model experience.